Drug Manufacturer Jacks Price Of Lifesaving Drug 1000 Percent
April 8, 2016

J. Michael Pearson is the CEO of Valeant Pharmaceuticals International, a company known for buying up drug patents and then jacking up the prices. He made over $10 million in compensation last year, between his salary and stock options.

Under Pearson's leadership, a drug used to treat a rare liver disease has risen in price from $4,000 a month to $44,000 per month, which is not only immoral, it ought to be entirely illegal.

Valeant's cynical explanation for their reasons for jacking up the prices will make you sick.

Valeant defended itself, saying in a statement that it “prices its treatments based on a range of factors, including clinical benefits and the value they bring to patients, physicians, payers and society.” It says patients are largely shielded from price increases by insurance and financial assistance programs the company offers, so that virtually no one is denied a drug they need.

Here's one man's story:

(h/t Boing Boing)

Help Us Fight Back Against Social Media Censorship

Facebook has been limiting the visibility of our posts after a serious of bogus violations. We need your help now more than ever.


We are currently migrating to Disqus

On May 14, 2022, we started migrating our comments from Insticator back to Disqus. During this transition period, some posts will have Insticator and some Disqus. For more information on the transition, as well as information regarding old C&L accounts, please see this post.

We welcome relevant, respectful comments. Any comments that are sexist or in any other way deemed hateful by our staff will be deleted and constitute grounds for a ban from posting on the site. Please refer to our Terms of Service for information on our posting policy.